-
公开(公告)号:US07932245B2
公开(公告)日:2011-04-26
申请号:US10691095
申请日:2003-10-22
申请人: Youssef L. Bennani , William H. Bunnelle , Sou-Jen Chang , Sanjay R. Chemburkar , Jinhua Chen , Michael J. Dart , Dilinie P. Fernando , Yi-Yin Ku , Mark Lockwood , Lei Wang
发明人: Youssef L. Bennani , William H. Bunnelle , Sou-Jen Chang , Sanjay R. Chemburkar , Jinhua Chen , Michael J. Dart , Dilinie P. Fernando , Yi-Yin Ku , Mark Lockwood , Lei Wang
IPC分类号: A61K31/397 , A61K31/535 , A61K31/4965 , A61K31/445
CPC分类号: C07C233/58 , A61K31/397 , A61K31/445 , A61K31/537 , A61K31/54 , C07C2602/50
摘要: The present invention relates to the use of compounds of formula (I) for the treatment of epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, or movement disorders, and to provide neuroprotection.
摘要翻译: 本发明涉及式(I)化合物用于治疗癫痫,双相情感障碍,精神障碍,偏头痛,疼痛或运动障碍的用途,并提供神经保护作用。
-
公开(公告)号:US20110098285A1
公开(公告)日:2011-04-28
申请号:US12849697
申请日:2010-08-03
申请人: Robert J. Altenbach , Lawrence A. Black , Sou-Jen Chang , Marlon D. Cowart , Ramin Faghih , Gregory A. Gfesser , Yi-Yin Ku , Huaqing Liu , Kirill A. Lukin , Diana L. Nersesian , Yu-ming Pu , Padam N. Sharma , Youssef L. Bennani , Michael P. Curtis
发明人: Robert J. Altenbach , Lawrence A. Black , Sou-Jen Chang , Marlon D. Cowart , Ramin Faghih , Gregory A. Gfesser , Yi-Yin Ku , Huaqing Liu , Kirill A. Lukin , Diana L. Nersesian , Yu-ming Pu , Padam N. Sharma , Youssef L. Bennani , Michael P. Curtis
IPC分类号: A61K31/40 , C07D207/04 , C07D401/02 , C07D403/02 , C07D413/02 , C07D417/02 , A61K31/4439 , A61K31/506 , A61K31/5355 , A61K31/541 , A61K31/4709 , A61K31/501 , A61P25/28 , A61P11/06 , A61P25/00 , A61P25/16 , A61P3/00 , A61P25/08 , A61P25/18 , A61P25/24 , A61P25/30 , A61P3/10 , A61P3/04
CPC分类号: C07D207/14 , C07D207/08 , C07D207/12 , C07D207/20 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/64 , C07D213/85 , C07D215/12 , C07D215/14 , C07D215/20 , C07D217/14 , C07D237/12 , C07D237/14 , C07D237/28 , C07D239/26 , C07D239/28 , C07D239/42 , C07D239/52 , C07D241/12 , C07D241/42 , C07D263/32 , C07D277/28 , C07D295/073 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/135 , C07D295/155 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物,使用这些化合物和组合物的方法,以及制备式(I)范围内的化合物的方法。
-
3.
公开(公告)号:US08106088B2
公开(公告)日:2012-01-31
申请号:US12847942
申请日:2010-07-30
申请人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
发明人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
IPC分类号: A61K31/4025 , A61K31/404 , C07D403/06 , C07D209/04
CPC分类号: C07D263/56 , C07D209/14 , C07D235/14 , C07D277/28 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物和使用这些化合物和组合物的方法。
-
4.
公开(公告)号:US20120108637A1
公开(公告)日:2012-05-03
申请号:US13335253
申请日:2011-12-22
申请人: Marlon D. COWART , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
发明人: Marlon D. COWART , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
IPC分类号: A61K31/455 , A61K31/428 , C07D417/14 , A61K31/4439 , C07D413/02 , A61K31/423 , A61P9/00 , A61P25/28 , A61P11/06 , A61P25/18 , A61P35/00 , A61P25/00 , A61P25/08 , A61P25/16 , C07D277/62
CPC分类号: C07D263/56 , C07D209/14 , C07D235/14 , C07D277/28 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物和使用这种化合物和组合物的方法。
-
5.
公开(公告)号:US20100298291A1
公开(公告)日:2010-11-25
申请号:US12847942
申请日:2010-07-30
申请人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
发明人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
IPC分类号: A61K31/397 , A61P25/28 , A61P11/06 , A61P9/10 , A61P25/30 , A61P25/00 , A61P3/10 , A61P25/06 , A61P25/16 , A61P25/18 , A61P3/00 , C07D417/02 , A61K31/428 , A61K31/4439 , C07D417/14 , A61K31/4709 , A61K31/506 , A61K31/55 , C07D413/02
CPC分类号: C07D263/56 , C07D209/14 , C07D235/14 , C07D277/28 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物和使用这些化合物和组合物的方法。
-
6.
公开(公告)号:US07358263B2
公开(公告)日:2008-04-15
申请号:US11357584
申请日:2006-02-16
IPC分类号: A61K31/428 , A61K31/4436 , A61K31/4439 , C07D417/06
CPC分类号: C07D263/56 , C07D209/14 , C07D235/14 , C07D277/28 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物和使用这些化合物和组合物的方法。
-
公开(公告)号:US20090054420A1
公开(公告)日:2009-02-26
申请号:US12196124
申请日:2008-08-21
申请人: Robert J. Altenbach , Lawrence A. Black , Sou-Jen Chang , Marlon D. Cowart , Ramin Faghih , Gregory A. Gfesser , Yi-Yin Ku , Huaqing Liu , Kirill A. Lukin , Diana L. Nersesian , Yu-ming Pu , Padam N. Sharma , Youssef L. Bennani , Michael P. Curtis
发明人: Robert J. Altenbach , Lawrence A. Black , Sou-Jen Chang , Marlon D. Cowart , Ramin Faghih , Gregory A. Gfesser , Yi-Yin Ku , Huaqing Liu , Kirill A. Lukin , Diana L. Nersesian , Yu-ming Pu , Padam N. Sharma , Youssef L. Bennani , Michael P. Curtis
IPC分类号: A61K31/541 , C07D207/09 , C07D401/02 , C07D413/02 , C07D239/02 , C07D277/02 , C07D403/02 , C07D417/02 , C07D403/14 , A61P3/00 , A61P35/00 , A61P11/06 , A61P25/00 , A61P9/00 , A61K31/4725 , A61K31/4709 , A61K31/40 , A61K31/4439 , A61K31/422 , A61K31/506 , A61K31/5377 , A61K31/426 , A61K31/501
CPC分类号: C07D207/14 , C07D207/08 , C07D207/12 , C07D207/20 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/64 , C07D213/85 , C07D215/12 , C07D215/14 , C07D215/20 , C07D217/14 , C07D237/12 , C07D237/14 , C07D237/28 , C07D239/26 , C07D239/28 , C07D239/42 , C07D239/52 , C07D241/12 , C07D241/42 , C07D263/32 , C07D277/28 , C07D295/073 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/135 , C07D295/155 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物,使用这些化合物和组合物的方法,以及制备式(I)范围内的化合物的方法。
-
8.
公开(公告)号:US07807697B2
公开(公告)日:2010-10-05
申请号:US12022041
申请日:2008-01-29
申请人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
发明人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
IPC分类号: A61K31/4184 , A61K31/4439 , A61K31/4025 , C07D401/02 , C07D401/14 , C07D235/02 , C07D207/04
CPC分类号: C07D263/56 , C07D209/14 , C07D235/14 , C07D277/28 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物和使用这些化合物和组合物的方法。
-
公开(公告)号:US07094790B2
公开(公告)日:2006-08-22
申请号:US10837162
申请日:2004-04-30
申请人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
发明人: Marlon D. Cowart , Yi-Yin Ku , Sou-Jen Chang , Dilinie P. Fernando , Timothy A. Grieme , Robert J. Altenbach
IPC分类号: A61K31/47 , C07D215/06
CPC分类号: C07D263/56 , C07D209/14 , C07D235/14 , C07D277/28 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/04 , C07D403/06 , C07D413/06 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/14
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands and methods for using such compounds and compositions.
-
公开(公告)号:US08273767B2
公开(公告)日:2012-09-25
申请号:US12849697
申请日:2010-08-03
申请人: Robert J. Altenbach , Lawrence A. Black , Sou-Jen Chang , Marlon D. Cowart , Ramin Faghih , Gregory A. Gfesser , Yi-Yin Ku , Huaqing Liu , Kirill A. Lukin , Diana L. Nersesian , Yu-ming Pu , Padam N. Sharma , Youssef L. Bennani , Michael P. Curtis
发明人: Robert J. Altenbach , Lawrence A. Black , Sou-Jen Chang , Marlon D. Cowart , Ramin Faghih , Gregory A. Gfesser , Yi-Yin Ku , Huaqing Liu , Kirill A. Lukin , Diana L. Nersesian , Yu-ming Pu , Padam N. Sharma , Youssef L. Bennani , Michael P. Curtis
IPC分类号: C07D413/02 , C07D417/02 , A61K31/4439 , A61K31/506
CPC分类号: C07D207/14 , C07D207/08 , C07D207/12 , C07D207/20 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/64 , C07D213/85 , C07D215/12 , C07D215/14 , C07D215/20 , C07D217/14 , C07D237/12 , C07D237/14 , C07D237/28 , C07D239/26 , C07D239/28 , C07D239/42 , C07D239/52 , C07D241/12 , C07D241/42 , C07D263/32 , C07D277/28 , C07D295/073 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/135 , C07D295/155 , C07D401/04 , C07D401/10 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
摘要翻译: 式(I)化合物可用于治疗由组胺-3受体配体预防或改善的病症或病症。 还公开了包含组胺-3受体配体的药物组合物,使用这些化合物和组合物的方法,以及制备式(I)范围内的化合物的方法。
-
-
-
-
-
-
-
-
-